Metabolomics analyses identify platelet activating factors and heme breakdown products as Lassa fever biomarkers.
Lassa fever afflicts tens of thousands of people in West Africa annually. The rapid progression of patients from febrile illness to fulminant syndrome and death provides incentive for development of clinical prognostic markers that can guide case management. The small molecule profile of serum from...
Main Authors: | Trevor V Gale, Timothy M Horton, Donald S Grant, Robert F Garry |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2017-09-01
|
Series: | PLoS Neglected Tropical Diseases |
Online Access: | http://europepmc.org/articles/PMC5619842?pdf=render |
Similar Items
Mastomys natalensis and Lassa Fever, West Africa
by: Emilie Lecompte, et al.
Published: (2006-12-01)
by: Emilie Lecompte, et al.
Published: (2006-12-01)
Risk maps of Lassa fever in West Africa.
by: Elisabeth Fichet-Calvet, et al.
Published: (2009-01-01)
by: Elisabeth Fichet-Calvet, et al.
Published: (2009-01-01)
Similar Items
-
Elevated l-threonine is a biomarker for Lassa fever and Ebola
by: Trevor V. Gale, et al.
Published: (2020-11-01) -
Endotheliopathy and Platelet Dysfunction as Hallmarks of Fatal Lassa Fever
by: Lucy E. Horton, et al.
Published: (2020-11-01) -
Pathogenesis of Lassa Fever
by: David H. Walker, et al.
Published: (2012-10-01) -
Data set on Lassa fever in post-conflict Sierra Leone
by: Jeffrey G. Shaffer, et al.
Published: (2019-04-01) -
Lassa viral hemorrhagic fever
by: Viroj Wiwanitkit
Published: (2020-01-01)